Roger Stoll
Director/Board Member bei DELCATH SYSTEMS, INC.
Vermögen: 44 404 $ am 31.03.2024
Profil
Roger G.
Stoll is an Independent Director at Delcath Systems, Inc. and a Director at BIOCOM.
He previously served as the President & Chief Executive Officer at Ohmeda, Inc. from 1991 to 1998.
From 2002 to 2012, he was the Executive Chairman at RespireRx Pharmaceuticals, Inc. He also held the position of Director at St. Jude Medical LLC from 1991 to 2002 and at Questcor Pharmaceuticals, Inc. from 1999 to 2005.
Additionally, he served as a Director at Chelsea Therapeutics International Ltd.
from 2008 to 2011 and at Agensys, Inc. from 2003 to 2007.
He was also a Director at Chelsea Therapeutics, Inc. and the Pharmaceutical Research & Manufacturers of America.
Prior to that, he held the position of Director at Boc Group Plc from 1991 to 1998 and Executive Vice President-North America Region at Fresenius Medical Care Holdings, Inc. from 1998 to 2001.
He started his career as EVP & GM-Worldwide Diagnostics Business Group at Bayer AG from 1986 to 1991 and as President-Consumer Health Care Group at Miles, Inc. He also served as the President-American Critical Care Division at American Hospital Supply Corp.
from 1976 to 1986.
Dr. Stoll obtained his undergraduate degree from Ferris State University (Michigan) and his doctorate degree from the University of Connecticut.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DELCATH SYSTEMS, INC.
0,04% | 28.03.2024 | 9 309 ( 0,04% ) | 44 404 $ | 31.03.2024 |
Aktive Positionen von Roger Stoll
| Unternehmen | Position | Beginn |
|---|---|---|
| DELCATH SYSTEMS, INC. | Director/Board Member | 16.02.2023 |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Director/Board Member | 16.06.2011 |
Ehemalige bekannte Positionen von Roger Stoll
| Unternehmen | Position | Ende |
|---|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Chief Executive Officer | 10.08.2012 |
| Chelsea Therapeutics, Inc. | Director/Board Member | 01.01.2008 |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Director/Board Member | 01.01.2007 |
| QUESTCOR PHARMACEUTICALS INC | Director/Board Member | 01.01.2005 |
| ST JUDE MEDICAL INC | Director/Board Member | 01.01.2002 |
Ausbildung von Roger Stoll
| Ferris State University (Michigan) | Undergraduate Degree |
| University of Connecticut | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Health Technology |
| BAYER AG | Health Technology |
| DELCATH SYSTEMS, INC. | Health Technology |
| Private Unternehmen | 12 |
|---|---|
St. Jude Medical LLC
 St. Jude Medical LLC Medical SpecialtiesHealth Technology St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN. | Health Technology |
Fresenius Medical Care Holdings, Inc.
 Fresenius Medical Care Holdings, Inc. Medical/Nursing ServicesHealth Services Fresenius Medical Care Holdings, Inc. provides kidney dialysis services and renal care products. It offers specialty pharmacy and laboratory services as well as manufacturing and distributing dialysis equipment, disposable products, and renal pharmaceuticals. The company was founded in 1996 and is headquartered in Waltham, MA. | Health Services |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. BiotechnologyHealth Technology Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases. The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC. | Health Technology |
Miles, Inc.
 Miles, Inc. Chemicals: Major DiversifiedProcess Industries Part of Bayer AG, Miles, Inc. is a chemical company. The private company is based in Pittsburgh, PA. | Process Industries |
| American Hospital Supply Corp. | Health Technology |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
| Chelsea Therapeutics, Inc. | Health Technology |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
| Ohmeda, Inc. | |
Boc Group Plc
 Boc Group Plc Chemicals: SpecialtyProcess Industries Boc Group Plc is a British company that manufactures and supplies industrial gases. The private company is based in Windlesham, UK. and has subsidiaries in China. | Process Industries |
